The authors present an analysis of the choice of sample sizes for demonstra
ting cost-effectiveness of a new treatment or procedure, when data on both
cost and efficacy will be collected in a clinical trial. The Bayesian appro
ach to statistics is employed, as well as a novel Bayesian criterion that p
rovides insight into the sample size problem and offers a very flexible for
mulation.